EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Olutasidenib Alone or in Combination With Azacitidine as a Bridge to Transplant in Relapsed/Refractory m IDH1 AML

Shira N Dinner, Justin M Watts, Jorge E Cortes, Jay Yang, Maria R Baer, Gail J Roboz, Karen W L Yee, Antonio Curti, David C Taussig, Jürgen Krauter, Thomas Prebet, Hua Tian und 5 weitere

European Journal of Haematology · 2026-12 · 117 (6) · 1671-1675

DOI: 10.1111/ejh.70284 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Journal of Haematology, online erschienen am 14.08.2026. Verfasst von Shira N Dinner und 16 weiteren Autor:innen. Beteiligte Einrichtung: Robert H. Lurie Comprehensive Cancer Center, Northwestern Hospital, Chicago, Illinois, USA. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Robert H. Lurie Comprehensive Cancer Center, Northwestern Hospital, Chicago, Illinois, USA.
  • Division of Hematology, Department of Medicine, University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Department of Medicine, Georgia Cancer Center, Augusta University, Augusta, Georgia, USA.
  • Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan, USA.
  • University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.
  • Department of Hematology and Medical Oncology, Weill Cornell Medicine and The New York Presbyterian Hospital, New York, New York, USA.

ORCID-Profile: Pierre Peterlin, Christian Récher, Stéphane de Botton

Zitieren

APA

Dinner, S. N., Watts, J. M., Cortes, J. E., Yang, J., Baer, M. R., Roboz, G. J., Yee, K. W. L., Curti, A., Taussig, D. C., Krauter, J., Prebet, T., Tian, H., Sheppard, A. D., Peterlin, P., Grove, C., Récher, C., & de Botton, S. (2026). Olutasidenib Alone or in Combination With Azacitidine as a Bridge to Transplant in Relapsed/Refractory m IDH1 AML. European Journal of Haematology, 117(6), 1671-1675. https://doi.org/10.1111/ejh.70284

Vancouver

Dinner SN, Watts JM, Cortes JE, Yang J, Baer MR, Roboz GJ, et al. Olutasidenib Alone or in Combination With Azacitidine as a Bridge to Transplant in Relapsed/Refractory m IDH1 AML. European Journal of Haematology. 2026;117(6):1671-1675. doi:10.1111/ejh.70284

BibTeX
@article{Dinner2026,
  author = {Dinner, Shira N and Watts, Justin M and Cortes, Jorge E and Yang, Jay and Baer, Maria R and Roboz, Gail J and Yee, Karen W L and Curti, Antonio and Taussig, David C and Krauter, Jürgen and Prebet, Thomas and Tian, Hua and Sheppard, Aaron D and Peterlin, Pierre and Grove, Carolyn and Récher, Christian and de Botton, Stéphane},
  title = {Olutasidenib Alone or in Combination With Azacitidine as a Bridge to Transplant in Relapsed/Refractory m IDH1 AML},
  journal = {European Journal of Haematology},
  year = {2026},
  volume = {117},
  number = {6},
  pages = {1671--1675},
  doi = {10.1111/ejh.70284}
}
Kostenlos starten →